Future challenges for drug delivery

被引:48
作者
Breimer, DD [1 ]
机构
[1] Leiden Univ, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands
关键词
D O I
10.1016/S0168-3659(99)00060-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:3 / 6
页数:4
相关论文
共 10 条
[2]  
BREIMER DD, 1994, PULSATILE DRUG DELIV, P25
[3]   TRANSLATING SAFETY, EFFICACY AND COMPLIANCE INTO ECONOMIC VALUE FOR CONTROLLED-RELEASE DOSAGE FORMS [J].
CRAMER, MP ;
SAKS, SR .
PHARMACOECONOMICS, 1994, 5 (06) :482-504
[4]  
FLORENCE AT, 1996, DRUG DELIVERY CO REP, P17
[5]   Controlled release technologies: Current status and future prospects [J].
Guy, R ;
Powell, M ;
Fix, J ;
Park, K .
PHARMACEUTICAL RESEARCH, 1996, 13 (12) :1759-1759
[6]  
*HAMBR QUIST INC, 1997, LIST MAJ PHARM PROD
[7]   RATE OF INCREASE IN THE PLASMA-CONCENTRATION OF NIFEDIPINE AS A MAJOR DETERMINANT OF ITS HEMODYNAMIC-EFFECTS IN HUMANS [J].
KLEINBLOESEM, CH ;
VANBRUMMELEN, P ;
DANHOF, M ;
FABER, H ;
URQUHART, J ;
BREIMER, DD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (01) :26-30
[8]  
SAM T, 1996, INNOVATIONS DRUG DEL
[9]   Oral protein drug delivery [J].
Wang, W .
JOURNAL OF DRUG TARGETING, 1996, 4 (04) :195-232
[10]  
1996, NATURE S, V384, P1